在长期响应瑞巴维林加上阿尔法干扰素的患者中,从慢性型肝炎中恢复
Lancet (London, England)
|July 13, 2000
概括
对干扰素α和利巴维林持续反应的患者从血清和肝脏中实现了长期的C型肝炎病毒RNA消除. 这表明从慢性型肝炎中完全康复,并观察到显著的组织病理改善.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性型肝炎仍然是全球重要的健康问题.
- 干扰素α和利巴维林已用于治疗型肝炎病毒 (HCV) 感染.
研究的目的:
- 评估持续响应干扰素α和利巴维林治疗的患者的长期结果.
- 为了确定是否可以实现完整的病毒清除和肝脏恢复.
主要方法:
- 研究人群:45名持续响应干扰素α和利巴维林的患者.
- 在血清和肝脏中评估病毒RNA水平.
- 评估肝脏组织病理学.
主要成果:
- 在血清和肝脏中观察到长期消除C型肝炎病毒RNA.
- 观察到组织病理学改善,表明肝损伤已恢复.
- 持续的病毒清除与改善的肝脏健康相关.
结论:
- 干扰素α和利巴维林治疗可以导致持续的,长期的病毒消除响应者.
- 从慢性型肝炎中完全康复,包括他的病理正常化是可能的.
- 这些发现支持组合疗法的疗效,以实现治愈.
相关概念视频
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


